Document Detail

The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis.
MedLine Citation:
PMID:  23188166     Owner:  NLM     Status:  Publisher    
The efficacy of sequential therapy of pazufloxacin (PZFX), which is a parenteral fluoroquinolone, followed by oral fluoroquinolones [tosufloxacin tosilate (TFLX) or levofloxacin (LVFX)] for treatment of pyelonephritis, was evaluated. Patients with pyelonephritis who had fever (≥37.5 °C), pyuria (≥10 white blood cells/high-power field), and bacteriuria (≥10(4) colony-forming units/ml) were eligible for this study. PZFX (500 mg) was given intravenously twice a day for at least 3 days. If the patients were clinically improved, TFLX (150 mg) or LVFX (100 mg) was then administered orally three times a day for at least 5 days. Patients underwent clinical and microbiological evaluation at 5-9 days after final drug administration. Clinical and microbiological efficacy could be assessed in 21 of 25 cases enrolled. Both clinical and microbiological efficacy rates were 81.0 % (17/21 cases). In the effective cases, the mean administration time was 4.2 days for PZFX and 6.0 days for oral fluoroquinolones. The mean time to defervescence was 3.4 days for the effective cases. In the four treatment failure cases, three quinolone-resistant Escherichia coli and a quinolone-resistant Enterococcus faecalis were isolated. This sequential therapy seemed to be clinically effective in the treatment of pyelonephritis; however, the prevalence of quinolone-resistant E. coli should be taken into account.
Koichi Takahashi; Tetsuro Muratani; Soichiro Akasaka; Yoji Yamada; Tetsuro Matsumoto
Related Documents :
2924596 - An evaluation of the ability of the peripheral vasodilator buflomedil to improve vascul...
24590816 - A bayesian approach to dose-finding studies for cancer therapies: incorporating later c...
16905946 - Oral l-arginine administration does not inhibit thrombosis on an experimental model of ...
7908606 - The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the ra...
6472556 - Behavioral toxicological assessment of oral pralidoxime methanesulfonate in the rat.
3996846 - Glucagon-evoked gastric dysrhythmias in humans shown by an improved electrogastrographi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-28
Journal Detail:
Title:  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy     Volume:  -     ISSN:  1437-7780     ISO Abbreviation:  J. Infect. Chemother.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9608375     Medline TA:  J Infect Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Urology, Fukuoka Shin-Mizumaki Hospital, 1-2-1, Tateyashiki, Mizumaki-machi, Onga-gun, 807-0051, Japan,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pretreatment performance status and nutrition are associated with early mortality of locally advance...
Next Document:  Effects of adherence to ventilator-associated pneumonia treatment guidelines on clinical outcomes.